Clinical Study
Role of Barium Esophagography in Patients with Locally Advanced Esophageal Cancer: Evaluation of Response to Neoadjuvant Chemoradiotherapy
Table 2
Tumor length, volume, and PES.
| | | Responders ( = 22) | Nonresponders ( = 12) | value |
| | Tumor length | | | | | Pretreatment (cm) | 5.5 ± 1.9 | | 0.336 | | Posttreatment (cm) | 4.5 ± 1.1 | | 0.018 | | Decrease (%) | 14.7 ± 16.1 | | 0.269 | | Tumor volume | | | | | Pretreatment (cm2) | 10.3 ± 7.6 | | 0.439 | | Posttreatment (cm2) | 4.0 ± 2.8 | | 0.445 | | Decrease (%) | 56.7 ± 24.9 | | 0.198 | | PES | | | | | Pretreatment (%) | 64.5 ± 12.9 | | 0.659 | | Posttreatment (%) | 33.0 ± 18.5 | | 0.018 | | Decrease (%) | 31.5 ± 13.9 | | <0.001 |
|
|
Note: data are means ± standard deviations. PES: percent esophageal stenosis.
|
